Bottom line
IYH vs RYHIX: the short answer
IYH (iShares U.S. Healthcare ETF) and RYHIX (Health Care Fund) share a meaningful slice of their top holdings — about 76% by weight.
IYH is cheaper at 0.37% vs 1.38% — a difference of $101 a year per $10,000 invested.
Over five years, IYH returned +7.0% a year vs +5.1% for RYHIX.
Updated Nov 19, 2026
IYH vs RYHIX side by side
| IYH | RYHIX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | iShares | Guggenheim |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.37% | 1.38% |
| Annual cost per $10k | $37 | $138 |
| 10-yr cost on $10k (prospectus) | $468 | $1,709 |
| Max front load | None | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +13.1% | +14.4% |
| 5-yr return (annualized) | +7.0% | +5.1% |
| 10-yr return (annualized) | +9.4% | +7.9% |
| Best quarter | +15.3% | +18.7% |
| Worst quarter | −12.7% | −14.4% |
| Net assets (fund) | $3.6B | $19.4M |
| Number of holdings | 103 | 135 |
| Portfolio turnover | 3% | 244% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IYH | RYHIX | Difference |
|---|---|---|---|
| 2025 | +13.1% | +14.4% | −1.3% |
| 2024 | +3.1% | +0.6% | +2.5% |
| 2023 | +2.1% | +5.8% | −3.8% |
| 2022 | −4.4% | −11.6% | +7.2% |
| 2021 | +23.4% | +19.2% | +4.2% |
| 2020 | +15.5% | +18.9% | −3.5% |
| 2019 | +20.8% | +22.8% | −2.0% |
| 2018 | +5.9% | +1.6% | +4.3% |
| 2017 | +22.3% | +23.5% | −1.2% |
| 2016 | −2.8% | −9.4% | +6.6% |
Source: Fund prospectus bar charts
Holdings overlap
21 of IYH's top 25 holdings also appear in RYHIX's top 25.
| Holding | IYH | RYHIX |
|---|---|---|
| Eli Lilly And Company | 15.11% | 3.63% |
| Johnson & Johnson | 10.17% | 2.88% |
| Abbvie Inc. | 7.32% | 2.52% |
| Unitedhealth Group Incorporated | 6.16% | 2.22% |
| Merck & Co., Inc. | 5.31% | 2.04% |
| Thermo Fisher Scientific Incorporated | 3.52% | 1.61% |
| Amgen Inc. | 3.42% | 1.56% |
| Abbott Laboratories | 3.02% | 1.42% |
| Gilead Sciences, Inc. | 2.66% | 1.39% |
| Pfizer Inc. | 2.35% | 1.25% |
| Bristol-myers Squibb Company | 2.20% | 1.22% |
| Intuitive Surgical, Inc. | 2.05% | 1.31% |
| Danaher Corporation | 2.03% | 1.30% |
| Vertex Pharmaceuticals Incorporated | 2.00% | 1.34% |
| Stryker Corporation | 1.86% | 1.21% |
Source: SEC Form N-PORT
IYH top 10
- Eli Lilly And Company — 15.11%
- Johnson & Johnson — 10.17%
- Abbvie Inc. — 7.32%
- Unitedhealth Group Incorporated — 6.16%
- Merck & Co., Inc. — 5.31%
- Thermo Fisher Scientific Incorporated — 3.52%
- Amgen Inc. — 3.42%
- Abbott Laboratories — 3.02%
- Gilead Sciences, Inc. — 2.66%
- Pfizer Inc. — 2.35%
RYHIX top 10
- Eli Lilly & Company — 3.63%
- Johnson & Johnson — 2.88%
- Abbvie Inc — 2.52%
- Unitedhealth Group Inc — 2.22%
- Merck & Company Inc — 2.04%
- Thermo Fisher Scientific Inc — 1.61%
- Amgen Inc — 1.56%
- Abbott Laboratories — 1.42%
- Gilead Sciences Inc — 1.39%
- Vertex Pharmaceuticals Inc — 1.34%
FAQ
What is the difference between IYH and RYHIX?
Which is cheaper, IYH or RYHIX?
Should I own both IYH and RYHIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.